Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Nikoletta Nikolenko.

Newcastle AuthorsTitleYearFull text
Cecilia Jimenez Moreno
Dr Nikoletta Nikolenko
Professor Grainne Gorman
Gabriella-Denisa Hathazi
Dr Sally Spendiff
et al.
Periostin as a blood biomarker of muscle cell fibrosis, cardiomyopathy and disease severity in myotonic dystrophy type 12023
Dr Nikoletta Nikolenko
Dr Marleny Jimenez-Castleton
Professor Grainne Gorman
Professor Hanns Lochmuller
Activities of daily living in myotonic dystrophy type 12019
Dr Cecilia Jimenez Moreno
Dr Nikoletta Nikolenko
Dr Alasdair Blain
Jane Newman
Jassi Sodhi
et al.
Analysis of the functional capacity outcome measures for myotonic dystrophy2019
Dr Cecilia Jimenez Moreno
Dr Sarah Charman
Dr Nikoletta Nikolenko
Maxwell Larweh
Professor Grainne Gorman
et al.
Analyzing walking speeds with ankle and wrist worn accelerometers in a cohort with myotonic dystrophy2019
Dr Nikoletta Nikolenko
Design, conduct, and use of patient preference studies in the medical product life cycle: A multi-method study2019
Dr Nikoletta Nikolenko
Dr Cecilia Jimenez Moreno
Professor Grainne Gorman
Professor Hanns Lochmuller
Disease burden of myotonic dystrophy type 12019
Dr Nikoletta Nikolenko
Patient Preferences in the Medical Product Life Cycle: What do Stakeholders Think? Semi-Structured Qualitative Interviews in Europe and the USA2019
Dr Chiara Marini Bettolo
Dr Nikoletta Nikolenko
Professor Hanns Lochmuller
Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries2019
Libby Wood
Dr Nikoletta Nikolenko
Professor Hanns Lochmuller
Benign and malignant tumors in the UK myotonic dystrophy patient registry2018
Dr Oksana Pogoryelova
Jose Gonzalez Coraspe
Dr Nikoletta Nikolenko
Professor Hanns Lochmuller
Dr Andreas Roos
et al.
GNE myopathy: From clinics and genetics to pathology and research strategies2018
Lindsay Wood
Dr Nikoletta Nikolenko
Dr Chiara Marini Bettolo
Professor Hanns Lochmuller
Survival patterns and cancer determinants in families with myotonic dystrophy type 12018
Dr Cecilia Jimenez Moreno
Cecilia Jimenez Moreno
Dr Nikoletta Nikolenko
Dr Jose Atalaia
Professor Michela Guglieri
et al.
Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA)2017
Dr Nikoletta Nikolenko
Impact of subarachnoid haemorrhage Canadian clinical decision rules for investigation of acute headache: a retrospective case note review2017
Libby Wood
Dr Isabell Cordts
Dr Jose Atalaia
Dr Chiara Marini Bettolo
Professor Volker Straub
et al.
The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research2017
Dr Nikoletta Nikolenko
Professor Hanns Lochmuller
DMD in Cyprus: Demographics and clinical characteristics2016
Dr Nikoletta Nikolenko
Dr Jose Atalaia
Dr Chiara Marini Bettolo
Professor Volker Straub
Professor Hanns Lochmuller
et al.
The UK Myotonic Dystrophy Patient Registry2016
Dr Nikoletta Nikolenko
Rehabilitation of children with progressive muscular dystrophy Duchenne (Реабилитация детей с прогрессирующей мышечной дистрофией Дюшенна)2014
Dr Nikoletta Nikolenko
Role of screening studies using computer and video technologies in diagnostics of abnormalities in children development and in rehabilitation organization (Значение скрининг-исследований с использованием компьютерных и видеотехнологий в выявлении отклонений в развитии детей и организации реабилитации. Вестник восстановительной медицины)2014
Dr Nikoletta Nikolenko
Use of virtual reality game systems in rehabilitation of children with progressive muscular dystrophies (Игровая система виртуальной реальности в реабилитации детей с прогрессирующими мышечными дистрофиями)2014